MedPath

Blueberry Effects on Dark Vision and Glare Recovery

Not Applicable
Completed
Conditions
Blindness and Low Vision
Interventions
Dietary Supplement: Blueberry Capsules S2
Dietary Supplement: Placebo Capsule S2
Dietary Supplement: Blueberry Juice S2
Dietary Supplement: Placebo Juice L1
Dietary Supplement: Blueberry Juice L1
Registration Number
NCT01942746
Lead Sponsor
Atlantic Food and Horticulture Research Center
Brief Summary

Clinical evidence for effects of plant anthocyanins on vision, and particularly night vision is controversial. Two clinical trials were conducted to investigate whether blueberry juice consumption affected visual dark adaptation, functional night vision, and recovery after photo-bleaching of the retina. One trial (S2) employed a 3 week intervention and washout period, and two doses of blueberries plus a placebo. The other trial (L1) employed a 12 week intervention plus an 8 week washout and tested one blueberry juice dose against a juice placebo.

Detailed Description

Vision Tests: 1. Dark adaptometry, 2. scotopic visual acuity, 3. scotopic contrast sensitivity, 4. rod/cone conversion, 5. recovery after retinal photobleaching

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • visual acuity better than 6/7.5 on EDTRS acuity chart at 2.5m
  • visual contrast sensitivity within normal range at 2.5m as tested on Visteck 3000
  • stereo acuity better than 80 seconds of arc on Frisby stereoacuity test
  • no ocular history other than refractive glasses
  • no family history of eye disease
Exclusion Criteria
  • family history of retinal degeneration, glaucoma, diabetes, hypertension, cataract, or amblyopia (dimness in vision).
  • evidence in subject (upon examination) of amblyopia (dimness in vision), manifest strabismus (unable to focus both eyes on one spot), or anisotropia (non-uniform responsiveness between both eyes).
  • intraocular pressure above 21mmHG from an average of three measures using Mentor tonopen-XL

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Blueberry CapsulesBlueberry Capsules S2Commercially prepared single strength blueberry juice which was composed of a 50:50 blend of two highbush blueberry species (Vaccinium corymbosum L. 'Rubel' and V. ashei Reade 'TifBlue')was freeze dried to a powder and encapsulated in gelatin capsules (Blueberry Capsules S2). Volunteers consumed 3 capsules/daily (7.11mg anthocyanin (as C3G eq) for 3 weeks.
PlaceboPlacebo Capsule S2Volunteers consumed in S2 three placebo capsules daily for 3 weeks. In L1 volunteers consumed 300ml placebo juice for twelve weeks. Placebo products contained no anthocyanins.
PlaceboPlacebo Juice L1Volunteers consumed in S2 three placebo capsules daily for 3 weeks. In L1 volunteers consumed 300ml placebo juice for twelve weeks. Placebo products contained no anthocyanins.
Blueberry JuiceBlueberry Juice S2Commercially prepared single strength blueberry juice which was composed of a 50:50 blend of two highbush blueberry species (Vaccinium corymbosum L. 'Rubel' and V. ashei Reade 'TifBlue'). Volunteers consumed 300 mls of juice/day (247-271 mg anthocyanins (as C3G) daily) while on this intervention, for either 3 weeks (Blueberry Juice S2) or 12 weeks (Blueberry Juice L1).
Blueberry JuiceBlueberry Juice L1Commercially prepared single strength blueberry juice which was composed of a 50:50 blend of two highbush blueberry species (Vaccinium corymbosum L. 'Rubel' and V. ashei Reade 'TifBlue'). Volunteers consumed 300 mls of juice/day (247-271 mg anthocyanins (as C3G) daily) while on this intervention, for either 3 weeks (Blueberry Juice S2) or 12 weeks (Blueberry Juice L1).
Primary Outcome Measures
NameTimeMethod
Rate of vision adaptation to low light after blueberry juice and placebo ingestion for 3 weeks (S2).Pre-intervention, and changes after 3 weeks of intervention, and again after 3 weeks of washout

Effect of blueberry products and placebo on the rate of vision adaptation to low light. The rate of vision adaptation is measured by lowest perceptible light intensity after 30 min of darkness (dark threshold); time to reach dark threshold (min); time to reach rod/cone transition (min) \[Time Frame: Pre-intervention, after 3 weeks intervention, again after a 3 week washout.\] \[Designated as safety issue: No\]

Rate of vision adaptation to low light after ingestion of blueberry juice and placebo for 12 weeks (L1).Preintervention, and changes after 8 and 12 weeks of intervention and after 4 and 8 weeks of washout

Effect of blueberry products and placebo on the rate of vision adaptation to low light. The rate of vision adaptation is measured by lowest perceptible light intensity after 30 min of darkness (dark threshold); time to reach dark threshold (min); time to reach rod/cone transition (min) \[Time Frame: Pre-intervention, after 8 and 12 weeks intervention, and again after 4 and 8 weeks washout\] \[Designated as safety issue: No\]

Secondary Outcome Measures
NameTimeMethod
Rate of recovery of visual acuity after retinal photostress (S2).Pre-intervention testing and testing for changes after 3 weeks of intervention and 3 weeks of washout

After dark adaptation testing (primary outcome) and contrast sensitivity and visual acuity testing (other pre-specified outcome measures), participants are subjected to photostress of the retina using bright light. The time (sec) required to recover pre-stress acuity is measured.

Rate of recovery of visual acquity after retinal photostress (L1).Pre-intervention and then testing for changes after 8 and 12 weeks of intervention and 4 and 8 weeks of washout.

After dark adaptation testing (primary outcome) and contrast sensitivity and visual acuity testing (other pre-specified outcome measures) participants are subjected to photostress of the retina using bright light. The time (sec) required to recover pre-stress acuity is measured.

Trial Locations

Locations (1)

Atlantic Food and Horicultural Research Center

🇨🇦

Kentville, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath